Food safety testing company Roka Bioscience sets terms for $75 million IPO

By
A A A

Roka Bioscience, which develops food safety testing equipment that uses molecular diagnostics, announced terms for its IPO on Monday. The Warren, NJ-based company plans to raise $75 million by offering 5.0 million shares at a price range of $14 to $16. At the midpoint of the proposed range, Roka Bioscience would command a fully diluted market value of $272 million.

Roka Bioscience, which was founded in 2009 and booked $3 million in sales for the 12 months ended March 31, 2014, plans to list on the NASDAQ under the symbol ROKA. Roka Bioscience initially filed confidentially on January 23, 2014. BofA Merrill Lynch, Leerink Partners, Cowen & Company and Wedbush PacGrow are the joint bookrunners on the deal.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: News Headlines , IPOs

Referenced Stocks: ROKA

Renaissance Capital

Renaissance Capital

More from Renaissance Capital:

Related Videos

Stocks

Referenced

100%

Most Active by Volume

106,679,460
  • $17.03 ▲ 0.47%
101,357,777
  • $38.65 ▼ 5.57%
61,830,117
  • $89.89 ▼ 4.26%
54,116,071
  • $5.11 ▼ 4.49%
50,121,934
  • $101.06 ▲ 0.10%
49,993,927
  • $3.52 ▼ 1.40%
47,717,687
  • $11.44 ▼ 4.67%
44,793,169
  • $99.05 ▼ 0.93%
As of 9/22/2014, 04:15 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com